HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS FOR SCHIZOPHRENIA PATIENTS INITIATING TYPICAL OR ATYPICAL ANTIPSYCHOTICS IN TIANJIN, CHINA

被引:0
|
作者
He, X. [1 ]
Wu, J. [1 ,2 ]
Jiang, Y.
Liu, L. [3 ]
Ye, W. Y. [3 ]
Xue, H. B. [3 ]
Montgomery, W. [4 ]
机构
[1] Tianjin Univ, Tianjin 300072, Peoples R China
[2] USC Sch Pharm, Los Angeles, CA USA
[3] Lilly Suzhou Pharmaceut Co Ltd, Shanghai Branch, Shanghai, Peoples R China
[4] Eli Lilly Australia Pty Ltd, Sydney, NSW, Australia
关键词
D O I
10.1016/j.jval.2014.03.1248
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMH29
引用
收藏
页码:A213 / A213
页数:1
相关论文
共 50 条
  • [41] Health care resource utilization among patients with depression before and after initiating vortioxetine
    Chue, P.
    Martins, K.
    Wong, K.
    Ahmed, G.
    Klarenbach, S.
    Richer, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S277 - S278
  • [42] HEALTH CARE RESOURCE UTILIZATION AND MEDICAL COSTS BEFORE AND AFTER INITIATION OF EPIDIOLEX IN COMMERCIALLY INSURED PATIENTS IN THE US
    Fang, G.
    Morse, A. M.
    Greco, T.
    Davies, K.
    Saurer, T.
    Viswanathan, H.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S112 - S112
  • [43] HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PALIPERIDONE PALMITATE VERSUS ORAL ATYPICAL ANTIPSYCHOTICS AMONG PATIENTS WITH SCHIZOAFFECTIVE DISORDER
    Pesa, J. A.
    Muser, E.
    Montejano, L. B.
    Kim, G.
    Smith, D. M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A118 - A119
  • [44] HEALTH CARE UTILIZATION AND EXPENDITURES OF OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATE IN TIANJIN, CHINA
    Yu, Q.
    Wu, J.
    Ma, F.
    Liu, J.
    Jin, L.
    Lin, M.
    Chang, J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A560 - A560
  • [45] HEALTH CARE UTILIZATION AND COSTS AMONG LUNG CANCER PATIENTS IN CHINA
    Zheng, Y.
    Wu, J.
    Xie, J.
    Xie, K.
    Yang, H. Y.
    Liu, J.
    Wu, E. Q.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A215 - A215
  • [46] Health care resource utilization and costs among patients with spasticity or cervical dystonia
    Hull, Michael
    Danchenko, Natalya
    Anupindi, Vamshi Ruthwik
    DeKoven, Mitchell
    He, Jing
    Bouchard, Jonathan
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (01): : 86 - 97
  • [47] MEDICATION USE PATTERNS, HEALTH-CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN FOR PATIENTS WITH SCHIZOPHRENIA IN BEIJING, CHINA
    Chen, Y.
    Cheng, Y.
    Shi, Q.
    Yu, X.
    Liu, Q.
    Gu, X.
    Shi, J.
    Montgomery, W.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A127 - A127
  • [48] Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus
    Lokhandwala, Tasneem
    Coutinho, Anna D.
    Bell, Christopher F.
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (08) : 1320 - 1335
  • [49] MEDICATION USE, HEALTH CARE RESOURCE USE AND DIRECT MEDICAL COSTS FOR PATIENTS WITH VERY-HIGH-RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN CHINA
    Zhao, B.
    He, X.
    Zhao, J.
    Wu, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S96 - S96
  • [50] ASSESSING THE RISK OF HOSPITALIZATION AND ASSOCIATED HEALTH CARE COSTS IN PATIENTS WITH BIPOLAR DISORDER TREATED WITH ATYPICAL ANTIPSYCHOTICS
    Bergeson, Gdovin J.
    Jing, Y.
    You, M.
    Forbes, R. A.
    Hebden, T.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A109 - A109